Literature DB >> 3821476

Tissue distribution and stability of metalloporphyrin MRI contrast agents.

R C Lyon, P J Faustino, J S Cohen, A Katz, F Mornex, D Colcher, C Baglin, S H Koenig, P Hambright.   

Abstract

Mn(III), Fe(III), and Gd(III) complexes of tetrakis(4-sulfonatophenyl)porphyrin (TPPS) and several other porphyrins were evaluated as potential MRI contrast agents. Based on consideration of relaxivity and stability properties in solution, MnTPPS was found to be the compound of choice. At pH 7 the Gd and Mn complexes significantly enhanced the water proton relaxation rate, while the relaxivity of FeTPPS exhibited a significant loss of relaxivity above pH 6 due to oxy-dimer formation. Although GdTPPS exhibited the highest relaxivity in solution, this property was rapidly lost due to dissociation of the metal ion. By contrast MnTPPS remained stable in human plasma after incubation for 9 days. Upon intravenous injection into athymic mice bearing subcutaneous human colon carcinoma xenografts, MnTPPS provided enhanced relaxation of the tissue water in several excised mouse tissues, notably kidney, liver, and tumor. The results at a fixed field (0.25 T) and relaxation dispersion studies showed decreases in water relaxation rates with time for kidney and liver, but an increase for the tumor, with a maximum near 4 days at the highest dose used.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3821476     DOI: 10.1002/mrm.1910040104

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  6 in total

1.  Localization and determination of infarct size by Gd-Mesoporphyrin enhanced MRI in dogs.

Authors:  P Herijgers; S K Laycock; Y Ni; G Marchal; J Bogaert; H Bosmans; C Petré; W Flameng
Journal:  Int J Card Imaging       Date:  1997-12

2.  In vivo imaging with a cell-permeable porphyrin-based MRI contrast agent.

Authors:  Taekwan Lee; Xiao-an Zhang; Shanta Dhar; Henryk Faas; Stephen J Lippard; Alan Jasanoff
Journal:  Chem Biol       Date:  2010-06-25

3.  Strategies for Target-Specific Contrast Agents for Magnetic Resonance Imaging.

Authors:  Sashiprabha M Vithanarachchi; Matthew J Allen
Journal:  Curr Mol Imaging       Date:  2012-10-01

4.  Small angle X-ray scattering study of meso-tetrakis (4-sulfonatophenyl) porphyrin in aqueous solution: a self-aggregation model.

Authors:  S C M Gandini; E L Gelamo; R Itri; M Tabak
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

5.  Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer.

Authors:  Mosa Alhamami; Weiran Cheng; Yuanyuan Lyu; Christine Allen; Xiao-An Zhang; Hai-Ling Cheng
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

6.  An enzyme-activatable and cell-permeable MnIII-porphyrin as a highly efficient T1 MRI contrast agent for cell labeling.

Authors:  Inga E Haedicke; Tan Li; Yong Le K Zhu; Francisco Martinez; Amanda M Hamilton; Donna H Murrell; Joris T Nofiele; Hai-Ling M Cheng; Timothy J Scholl; Paula J Foster; Xiao-An Zhang
Journal:  Chem Sci       Date:  2016-03-16       Impact factor: 9.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.